Navigation Links
Diagenode Gains Exclusive Rights to New ChIPmentation Technology for Chromatin Immunoprecipitation with High Throughput Sequencing
Date:9/28/2018

Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, has now gained exclusive rights to the ChIPmentation technology which it launched late last year from the Research Center of Molecular Medicine of the Austrian Academy of Sciences (CEMM). The ChIPmentation system encompasses a unique methodology that integrates chromatin immunoprecipitation with a ligation-free library preparation for high-throughput sequencing , ChIPmentation.

Diagenode’s ChIPmentation, based on the well-studied “tagmentation” technology, is designed to make ChIP-seq easier and much faster, making it more accessible to new researchers who may not be well-versed with the method. ChIPmentation combines both chromatin immunoprecipitation and library preparation using transposase and sequencing-compatible adaptors within the same protocol. Because the method results in reduced material loss, smaller starting amounts can be used, enabling the use of ChIP-seq in a wider range of projects such as those using rare cell types.

“Our exclusive license agreement with the CeMM for ChIPmentation reinforces our commitment to furthering epigenetics research as we are now able to dedicate more resources to further this technology and its adoption,” said Didier Allaer, CEO of Diagenode. “Diagenode has released a new manual solution for histone ChIPmentation, and will soon release a similar solution for transcription factors. We look forward to launching more customized solutions and services using ChIPmentation as a result of our new agreement.”
“Our ChIPmentation system represents true innovation in ChIP-seq,” said Jerome Kroonen, Ph.D., Global Marketing Manager at Diagenode. “The protocol eliminates the tedious steps, purifications, and inefficiencies that can result from standard ChIP-seq protocols. Additionally, researchers will have more options available for ChIPmentation including specifically optimized solutions for histones and transcription factors for tricky samples as we launch more kits.”

Kroonen also elaborated, “Initially the company launched an automated ChIPmentation system which incorporated the ChIPmentation protocol on its signature automation instrument, the IP-Star? Compact Automated System. As a result of dedicating more resources to developing solutions that our customers seek, we now provide the first solution for manual ChIPmentation, providing more flexibility for researchers.”

View data that has been generated with ChIPmentation and learn more about Diagenode’s newest ChIPmentation of histones solution at https://www.diagenode.com/en/categories/chromatin-ip-chipmentation

About Diagenode:
Diagenode is a leading provider of complete solutions for epigenetics research and sample preparation. The company has developed both shearing solutions for a number of applications as well as a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative DNA and chromatin shearing and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company’s latest innovations include the industry’s most validated ChIP antibodies, CATS-based RNA sequencing, and epigenetics assay services. For more information about Diagenode, please visit the company’s website at http://www.diagenode.com.

Read the full story at https://www.prweb.com/releases/diagenode_gains_exclusive_rights_to_new_chipmentation_technology_for_chromatin_immunoprecipitation_with_high_throughput_sequencing/prweb15797433.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Diagenode Announces Acquisition of Service Provider NXT-Dx to Complement Epigenetics Assay Services
2. WaferGen Bio-systems Regains Compliance with Nasdaq Listing Requirements
3. Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control
4. Clinical results indicate vaccine candidate highly efficacious against bacterial diarrhea
5. Rare genetic disease protects against bipolar disorder
6. Scientists wield plant viruses against deadly human disease
7. NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer
8. Smithsonian scientists discover corals best defender against an army of sea stars
9. Spot on against autoimmune diseases and chronic inflammations
10. Scientists create new designer proteins in fight against Alzheimers and cancer
11. Immune system is key ally in cyberwar against cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... Colo. (PRWEB) , ... July 18, 2019 , ... ... announced the addition of Meredith James, HT, PMP, to its executive team as ... over 20 years in drug development. In her new role, Ms. James is ...
(Date:7/17/2019)... ... July 17, 2019 , ... ... in the Southeast, and its acclaimed pediatric urologists are among the professionals ... This annual recognition signifies excellence among the country’s pediatric healthcare landscape. , ...
(Date:7/17/2019)... ... 15, 2019 , ... RCH Solutions (RCH), a ... companies, announces the availability of new specialty advisory practice, a Public Cloud Managed ... emerging bio-pharma companies interested in achieving specific outcomes related to public Cloud adoption. ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... , ... July 08, 2019 , ... ... The company’s SmartLight Indicator was recognized as the 2019 Innovative Product of the ... forward. The prestigious awards were during Sensors Expo & Conference 2019, ...
(Date:6/26/2019)... ... 26, 2019 , ... Alice Branton today released research results from preclinical trials ... Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The preclinical trial ... in crystallite size , Over 142% increase in particle size , ...
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, Inc ... (IND) application to the FDA for use of a person’s own adipose-derived stem cells ... of osteoarthritis in the knee. This IND is the first of several planned ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... distribution network with the appointment of Biofeedback Tech Ltd as its ... are an essential part of many therapeutic treatments and clinical assessment protocols to ...
Breaking Biology Technology: